MEDxAI Innovations Develops AI Platforms For Cervical Cancer Screening And Drug Discovery

Can artificial intelligence help improve cancer screening and accelerate drug discovery? Vellore-based MEDxAI Innovations, founded by Dr. Sheena C. Pravin, is developing solutions at the intersection of AI and healthcare. The VIT-incubated startup showcased two platforms during its interaction with Prime Minister Narendra Modi.

Its first platform, CerviLens, uses AI-assisted colposcopy and Pap smear analysis to support cervical cancer pre-screening and clinical decision-making. The second, Quantum PharmX, applies AI and computational techniques to drug discovery and molecular research, highlighting the startup’s focus on technology-driven healthcare innovation.

#HealthTech #AIHealthcare #DrugDiscovery #Startup77